Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Refardt

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 2, 2018
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Hypothalamic-Pituitary-Adrenal Axis in Healthy VolunteersBettina Winzeler, Ismael da Conceição, Julie Refardt, et al.
European Journal of Endocrinology|April 15, 2026
Response to Letter to the Editor: « Re-evaluating GLP-1 receptor agonist-associated changes in copeptin »Svenja Leibnitz, Bettina Winzeler, Julie Refardt, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2023
Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated HyponatremiaLaura Potasso, Sophie Monnerat, Julie Refardt, et al.
Endocrine|July 6, 2020
Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteersBettina Winzeler, Ismael da Conceição, Julie Refardt, et al.
European Journal of Endocrinology|October 19, 2024
Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation testsChiara Angela Bizzozero, Sophie Monnerat, Fiona A Chapman, et al.
European Journal of Endocrinology|January 12, 2026
Effects of GLP-1 Receptor Agonists on Copeptin in Euvolemic ParticipantsSvenja Leibnitz, Bettina Winzeler, Julie Refardt, et al.
Endocrine-Related Cancer|May 20, 2025
Impact of multikinase inhibitors in reshaping the treatment of advanced gastroenteropancreatic neuroendocrine tumorsAlexander R Siebenhüner, Julie Refardt, Guillaume P Nicolas, et al.
Clinical Endocrinology|October 20, 2022
Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia compared to healthy controlsClara O Sailer, Jill M Kuehne, Ismael da Conceição, et al.
Endocrine Connections|December 4, 2019
Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresisBettina Winzeler, Michelle Steinmetz, Julie Refardt, et al.
European Journal of Endocrinology|May 13, 2022
Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patientsJulie Refardt, Tessa Brabander, Noémie S Minczeles, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|October 2, 2018
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Hypothalamic-Pituitary-Adrenal Axis in Healthy VolunteersBettina Winzeler, Ismael da Conceição, Julie Refardt, et al.
European Journal of Endocrinology|April 15, 2026
Response to Letter to the Editor: « Re-evaluating GLP-1 receptor agonist-associated changes in copeptin »Svenja Leibnitz, Bettina Winzeler, Julie Refardt, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2023
Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated HyponatremiaLaura Potasso, Sophie Monnerat, Julie Refardt, et al.
Endocrine|July 6, 2020
Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteersBettina Winzeler, Ismael da Conceição, Julie Refardt, et al.
European Journal of Endocrinology|October 19, 2024
Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation testsChiara Angela Bizzozero, Sophie Monnerat, Fiona A Chapman, et al.
European Journal of Endocrinology|January 12, 2026
Effects of GLP-1 Receptor Agonists on Copeptin in Euvolemic ParticipantsSvenja Leibnitz, Bettina Winzeler, Julie Refardt, et al.
Endocrine-Related Cancer|May 20, 2025
Impact of multikinase inhibitors in reshaping the treatment of advanced gastroenteropancreatic neuroendocrine tumorsAlexander R Siebenhüner, Julie Refardt, Guillaume P Nicolas, et al.
Clinical Endocrinology|October 20, 2022
Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia compared to healthy controlsClara O Sailer, Jill M Kuehne, Ismael da Conceição, et al.
Endocrine Connections|December 4, 2019
Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresisBettina Winzeler, Michelle Steinmetz, Julie Refardt, et al.
European Journal of Endocrinology|May 13, 2022
Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patientsJulie Refardt, Tessa Brabander, Noémie S Minczeles, et al.
Pageof 9